Delcath Systems (DCTH) Fundamentals 2026 — P/E 789.1x, Revenue Analysis | SniperIQ

2.63 on the NASDAQ. This SniperIQ fundamentals page covers Delcath Systems's valuation (P/E 789.1x, P/B 4.0x), profitability (net margin 0.6%), revenue ($85M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Delcath Systems's market cap?

Delcath Systems (DCTH) has a market capitalization of approximately $436M, trading at

2.63 on the NASDAQ. Market cap moves with the live share price.

What is Delcath Systems's P/E ratio?

Delcath Systems's trailing twelve-month P/E ratio is 789.1x, with a price-to-book (P/B) of 4.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Delcath Systems?

Delcath Systems runs a net profit margin of 0.6%, a gross margin of 86.0%, and an operating margin of -1.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Delcath Systems generate?

Delcath Systems reported revenue of $85M for fiscal year 2025, with net income of

M and earnings per share (EPS) of -0.052. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Delcath Systems pay a dividend?

Delcath Systems does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Delcath Systems financially healthy?

Delcath Systems carries a debt-to-equity ratio of 0.01x and a current ratio of 11.24x, with a market beta of 0.49. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Delcath Systems a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Delcath Systems (DCTH) the key facts are: market cap $436M, P/E 789.1x, revenue $85M, 52-week range 8.12-13.74. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.